NASDAQ:ABVC | Free Cash Flow | ABVC BIOPHARMA, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$894,243.00
2025-12-31-$1.42M
2025-03-31-$539,833.00
2024-12-31-$702,134.00
2024-03-31-$955,816.00
2023-12-31-$430,463.00$0.00-$430,463.00
2023-03-31-$1.5M
2022-12-31-$461,069.00$89.00-$461,158.00
2022-03-31-$2.99M$93,220.00-$3.09M
2021-12-31-$2.52M$0.00-$2.52M
2021-03-31-$1.41M
2020-12-31-$2.19M
2020-03-31-$630,944.00
2019-12-31-$1.5M
2019-03-31-$599,528.00
2018-12-31$267,769.00
2018-03-31-$525,510.00
2017-12-31-$108,519.00
2017-03-31-$862,235.00
2016-12-31-$154,892.00
2016-09-30-$211,367.00
2015-12-31-$874,279.00
2015-09-30$1,100.00
2014-12-31$0.00
2014-09-18$1,238.00
2013-12-31-$10.00
2013-09-30$0.00$0.00$0.00
2012-12-31-$36,350.00$0.00-$36,350.00
2012-09-30-$94,168.00$0.00-$94,168.00
2011-12-31-$366,630.00$350.00-$366,980.00
2010-12-31-$153,363.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$2.99M
2024-12-31-$1.81M
2023-12-31-$4.19M$21,201.00-$4.21M
2022-12-31-$7.4M$119,692.00-$7.52M
2021-12-31-$7.6M$17,503.00-$7.62M
2020-12-31-$4.56M
2019-12-31-$3.13M
2018-12-31-$900,531.00
2017-12-31-$1.49M
2017-09-30-$1.6M
2016-09-30-$3.47M
2015-09-30$3,360.00
2014-09-18$1,168.00
2013-09-30-$37,768.00$0.00-$37,768.00
2012-09-30-$915,124.00$350.00-$915,474.00
2011-09-30-$1.59M$29,817.00-$1.62M